Selection Criteria for Active Surveillance of Patients with Prostate Cancer in Korea: A Multicenter Analysis of Pathology after Radical Prostatectomy

키워드

참고문헌 (30)

1. Heidenreich A, "EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intentupdate 2013", Eur Urol, 65, pp.124~137 (2014)[DOI]
2. Mohler JL, "Prostate cancer, version 2.2014", J Natl Compr Canc Netw., 12, pp.686~718 (2014)[DOI]
3. Klotz L, "Long-term follow-up of a large active surveillance cohort of patients with prostate cancer", J Clin Oncol, 33, pp.272~277 (2015)
4. D'Amico AV, "Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer", JAMA, 280, pp.969~974 (1998)[DOI]
5. 변석수, "Recent Changes in the Clinicopathologic Features of Korean Men with Prostate Cancer: A Comparison with Western Populations", Yonsei Medical Journal, 53(3), pp.543~549 (2012), 연세대학교의과대학[DOI]
6. Jeong CW, "Nomograms to predict the pathological stage of clinically localized prostate cancer in Korean men: comparison with western predictive tools using decision curve analysis", Int J Urol, 19, pp.846~852 (2012)[DOI]
7. Kang M, "Pre- and post-operative nomograms to predict recurrence-free probability in korean men with clinically localized prostate cancer", PLoS One, 9, pp.e100053~ (2014)[DOI]
8. Kim TH, "Pathological upgrading and upstaging of patients eligible for active surveillance according to currently used protocols", Int J Urol, 21, pp.377~381 (2014)[DOI]
9. Lee DH, "Comparison of pathological outcomes of active surveillance candidates who underwent radical prostatectomy using contemporary protocols at a high-volume Korean center", Jpn J Clin Oncol, 42, pp.1079~1085 (2012)[DOI]
10. 정문수, "Current status of active surveillance in prostate cancer", Investigative and Clinical Urology, 57(1), pp.14~20 (2016), 대한비뇨의학회[DOI]
11. Ploussard G, "The contemporary concept of significant versus insignificant prostate cancer", Eur Urol, 60, pp.291~303 (2011)[DOI]
12. Jeong SJ, "Development and validation of nomograms to predict the recovery of urinary continence after radical prostatectomy: comparisons between immediate, early, and late continence", World J Urol, 32, pp.437~444 (2014)[DOI]
13. Whitson JM, "The relationship between prostate specific antigen change and biopsy progression in patients on active surveillance for prostate cancer", J Urol, 185, pp.1656~1660 (2011)[DOI]
14. van den Bergh RC, "Prospective validation of active surveillance in prostate cancer: the PRIAS study", Eur Urol, 52, pp.1560~1563 (2007)[DOI]
15. Soloway MS, "Careful selection and close monitoring of lowrisk prostate cancer patients on active surveillance minimizes the need for treatment", Eur Urol, 58, pp.831~835 (2010)[DOI]
16. Carter HB, "Expectant management of prostate cancer with curative intent: an update of the Johns Hopkins experience", J Urol, 178, pp.2359~2364 (2007)[DOI]
17. Adamy A, "Role of prostate specific antigen and immediate confirmatory biopsy in predicting progression during active surveillance for low risk prostate cancer", J Urol, 185, pp.477~482 (2011)[DOI]
18. Torre LA, "Global cancer statistics, 2012", CA Cancer J Clin, 65, pp.87~108 (2015)[DOI]
19. Jeong IG, "Differences in the aggressiveness of prostate cancer among Korean, Caucasian, and African American men: a retrospective cohort study of radical prostatectomy", Urol Oncol, 34, pp.3~ (2016)
20. Raymundo EM, "Prostate cancer in Asian Americans: incidence, management and outcomes in an equal access healthcare system", BJU Int, 107, pp.1216~1222 (2011)[DOI]
21. Reese AC, "Expanded criteria to identify men eligible for active surveillance of low risk prostate cancer at Johns Hopkins: a preliminary analysis", J Urol, 190, pp.2033~2038 (2013)[DOI]
22. Mizuno K, "Evaluation of predictors of unfavorable pathological features in men eligible for active surveillance using radical prostatectomy specimens: a multi-institutional study", Jpn J Clin Oncol, 46, pp.1156~1161 (2016)
23. Bokhorst LP, "A decade of active surveillance in the PRIAS study: an update and evaluation of the criteria used to recommend a switch to active treatment", Eur Urol, 70, pp.954~960 (2016)[DOI]
24. Sugimoto M, "Should inclusion criteria for active surveillance for low-risk prostate cancer be more stringent? From an interim analysis of PRIAS-JAPAN", World J Urol, 33, pp.981~987 (2015)[DOI]
25. Choo SH, "Predictive factors of unfavorable prostate cancer in patients who underwent prostatectomy but eligible for active surveillance", Prostate Int, 2, pp.70~75 (2014)[DOI]
26. Lim SK, "Yonsei criteria: a new protocol for active surveillance in the era of robotic and local ablative surgeries", Clin Genitourin Cancer, 11, pp.501~507 (2013)[DOI]
27. Kakehi Y, "Prospective evaluation of selection criteria for active surveillance in Japanese patients with stage T1cN0M0 prostate cancer", Jpn J Clin Oncol, 38, pp.122~128 (2008)[DOI]
28. Epstein JI, "The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma", Am J Surg Pathol, 29, pp.1228~1242 (2005)[DOI]
29. Jeong CW, "The role of 3-tesla diffusion-weighted magnetic resonance imaging in selecting prostate cancer patients for active surveillance", Prostate Int, 2, pp.169~175 (2014)[DOI]
30. Park BH, "Role of multiparametric 3.0-Tesla magnetic resonance imaging in patients with prostate cancer eligible for active surveillance", BJU Int, 113, pp.864~870 (2014)[DOI]

관련 논문AI추천